The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Immune characterization of urothelial bladder carcinoma integrating transurethral resection of bladder tumor (TURBT) samples and serum: A feasibility study.
 
Carmen Alvarez-Dominguez
No Relationships to Disclose
 
Ainara Azueta
No Relationships to Disclose
 
Nerea Muñoz Unceta
No Relationships to Disclose
 
Jose Luis Gutierrez-Baños
No Relationships to Disclose
 
Hector Teran
No Relationships to Disclose
 
Javier Ocejo-Viñals
No Relationships to Disclose
 
Elena Gonzalez-Lopez
No Relationships to Disclose
 
Belen Caramelo
No Relationships to Disclose
 
Sara Marcos-Gonzalez
No Relationships to Disclose
 
David Salcines-Cuevas
No Relationships to Disclose
 
Mario Dominguez
No Relationships to Disclose
 
Rebeca Madureira-Rivero
No Relationships to Disclose
 
Felix Campos-Juanatey
No Relationships to Disclose
 
Marta Sotelo
No Relationships to Disclose
 
Andrea Zeoli
No Relationships to Disclose
 
Laura Revuelta
No Relationships to Disclose
 
Ignacio Duran
Honoraria - Astellas Pharma; Bristol-Myers Squibb; EUSA Pharma; Ipsen; Janssen Oncology; MSD Oncology; Roche/Genentech
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Immunomedics; Janssen Oncology; MSD Oncology; Novartis; Pharmacyclics; Roche/Genentech; Seagen
Research Funding - Astellas Pharma (Inst); AstraZeneca Spain (Inst); Janssen Oncology (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - AstraZeneca Spain; Ipsen; Roche/Genentech